KLK3 and prostate carcinoma: Screening for serum prostate-specific antigen (PSA) levels, digital rectal examination, magnetic resonance imaging (MRI), and prostate biopsy guided by transrectal ultrasound (TRUS) in patients with abnormal results is the standard diagnostic method for clinically significant prostate cancer (csPCa) [2].